Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7986
Reference
MSAN(2023)26
Name
Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
HEALTH BOARDS
PHARMACEUTICAL SERVICES
SUPPLIES
DRUG SHORTAGES
Description
Lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices are being discontinued and stock will be exhausted by w/c 18th December 2023. Please refer to the Medicines Supply Tool on the Specialist Pharmacy Service (SPS) website for a supply update of other glucagon-like peptide receptor agonists (GLP-1 RA) and clinical guidance on alternative treatment options. Information in the National Patient Safety Alert (NatPSA) on the shortage of GLP-1 receptor agonists issued on the 18thJuly 2023 can be used to guide management of patients switching from lixisenatide.
Contact Name
Contact Email
Contact Address
Pharmacy & Medicines Division 1st Floor East Rear St Andrew’s House EDINBURGH EH1 3DG
Created
2023-09-29 00:00:00
Click to go back to homepage